State of Possible: IMMEDIATE Therapeutics is developing a medicine for the critical time before heart attack sufferers make it to the hospital
- 2 days ago
- 1 min read
CEO Atul Deshpande describes how every minute counts after a heart attack yet patients typically do not receive and medicine until they reach the hospital. He explains what IMMEDIATE's solution is, which is phase 3 ready and has a SPA from FDA.









.png)
